Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor ungefähr 8 Monaten |
| Titel | Datum |
|---|---|
| MISC set for a technical breakout, says RHB Retail Research | vor 11 Tagen |
| MISC takes delivery of Seri Elbert - its sixth very large ethane carrier | vor ungefähr 2 Monaten |
| Research houses keep upbeat stance on MISC as 1Q results within expectations | vor ungefähr 2 Monaten |
| Inari, Sime Darby Property, Maybank, IHH Healthcare, Pharmaniaga, AirAsia, MISC... | vor ungefähr 2 Monaten |
| MISC 1Q net profit at RM430m versus net loss of RM1.16b a year earlier | vor ungefähr 2 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |